Vnitr Lek 2018, 64(9):887-892 | DOI: 10.36290/vnl.2018.122

Outpatient treatment of proximal deep vein thrombosis

Dalibor Musil
I. interní klinika kardiologická LF UP a FN Olomouc

The treatment of deep vein thrombosis (DVT) is based on anticoagulation with heparin, warfarin and direct oral anti-coagulants. According to the 9th ACCP Recommendation, for patients with DVT of the lower limbs, where the clinical state and home conditions permit, preference is given to home treatment over hospitalization. Despite that, the majority of patients with acute DVT still tend to be hospitalized, in particular when proximal thrombosis from the popliteal vein upward is involved. Furthermore, the recommendations do not describe proximal (iliofemoral) DVT as exceptional and more serious. Randomized and observation studies have shown faster relief from pain and swelling in patients keeping to the regimen of early mobilization wearing compression means, compared to patients keeping bed rest, while the incidence of new cases of PE was the same for both groups. In the acute phase of the disease compression and walking exercise is essential which, along with internal thrombolytic mechanisms of the body, accelerates recanalization and development of the collateral blood vessels in the deep muscular compartment of the lower limb. Two case studies demonstrate an outpatient approach to the therapy of proximal DVT.

Keywords: compression treatment; direct oral anticoagulants; low molecular weight heparin; venous thromboembolism

Received: August 29, 2018; Published: September 1, 2018  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Musil D. Outpatient treatment of proximal deep vein thrombosis. Vnitr Lek. 2018;64(9):887-892. doi: 10.36290/vnl.2018.122.
Download citation

References

  1. Kearon C, Akl EA, Ornelas J et al. Antithrombotic Therapy for VTE Disease: CHEST Guideline and Expert Panel Report. Chest 2016; 149(2): 315-352. Go to original source... Go to PubMed...
  2. Bultas J, Karetová D. Nízkomolekulární hepariny - jejich význam v současné praxi. Interní Med 2011; 13(11): 440-444.
  3. Hacobian M, Shetty R, Niles CM et al. Once daily enoxaparin for outpatient treatment of acute venous thrombosis: a case-control study. Clin Appl Thromb Hemost 2010; 16(1): 21-25. Go to original source... Go to PubMed...
  4. Guyatt HG, Akl EA, Crowther M et al. Atithrombotic therapy and prevention of thrombosis, 9th ed: American College of Chest Physicians, evidence-based clinical practice guidelines. Chest 2012; 141 (Suppl 2): 7S-47S. Go to original source...
  5. Masuda EM, Kessler DM, Kistner RL et al. The natural history of calf vein thrombosis: lysis of thrombi and development of reflux. J Vasc Surg 1998; 28(1): 67-73. Go to original source... Go to PubMed...
  6. Musil D. Regrese hluboké žilní trombózy. Vnitř Lék 2000; 56(1): 16-18.
  7. Bergan JJ, Schmid-Schönbein GW, Coleridge Smith PD et al. Chronic venous disease. N Engl J Med 2006; 355(5): 488-498. Go to original source... Go to PubMed...
  8. Kearon C, Kahn SR, Agnelii G et al. Antithrombotic therapy for venous thromboembolic disease: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition). Chest 2008; 133(Suppl 6): 454S-545S. Go to original source...
  9. Chen G, Shi W, He X et al. Feasibility of continuous, catheter-directed thrombolysis using low-dose urokinase in combination with low molecular-weight heparin for acute iliofemoral venous thrombosis in patients at risk of bleeding. Exp Ther Med. 2017; 13(2): 751-758. Go to original source... Go to PubMed...
  10. Enden T, Haig Y, Kløw NE et al. Long-term outcome after additional catheter-directed thrombolysis versus standard treatment for acute iliofemoral deep vein thrombosis (the CaVenT study): a randomised controlled trial. Lancet 2012; 379(9810): 31-38. Go to original source... Go to PubMed...
  11. Vendantham S, Goldhaber SZ, Julian JA et al. Pharmacomechanical catheter-directed thrombolysis for deep-vein thrombosis. N Engl J Med 2017; 377(23): 2240-2252. Go to original source... Go to PubMed...




Vnitřní lékařství

Madam, Sir,
please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

I declare:

  1. that I have met the above instruction
  2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited


No

Yes

If your statement is not true, please be aware
that brings the risk of danger to their health or the health of others.